5
Views
0
CrossRef citations to date
0
Altmetric
CORONARY ATHEROSCLEROSIS

Reversing coronary atherosclerosis

How to put findings of recent trials to practical use

Pages 50-65 | Published online: 05 Dec 2017
 

Preview

Results of recently completed and ongoing trials may change the thinking on how to treat atherosclerosis. For example, even faithful adherence to the American Heart Association step 2 diet may not halt progression of established coronary artery disease. Also, current goals of lipid-lowering therapy may be inadequate to reverse coronary artery narrowings. Dr Kahn describes studies that have used more drastic measures to control hyperlipidemia, the effects of these measures on coronary atherosclerosis, and clinical application of results.

Additional information

Notes on contributors

Joel K. Kahn

Joel K. Kahn, MD Dr Kahn is clinical assistant professor of medicine, University of Michigan Medical School, Ann Arbor; an attending cardiologist, William Beaumont Hospitals, Royal Oak and Troy, Michigan; and a staff member with Michigan Heart Group, Troy. His professional interests include prevention of coronary artery disease through risk-factor reduction and treatment with angioplasty and atherectomy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.